Gabelli Securities INC Upped Its Aetna INC (B:Aet) Com (AET) Holding

Aetna Inc. (NYSE:AET) LogoInvestors sentiment increased to 0.94 in Q2 2018. Its up 0.26, from 0.68 in 2018Q1. It increased, as 40 investors sold AET shares while 307 reduced holdings. 85 funds opened positions while 240 raised stakes. 264.38 million shares or 1.91% less from 269.52 million shares in 2018Q1 were reported. Ferguson Wellman Management invested in 71,269 shares or 0.46% of the stock. Moreover, Smithfield Trust Company has 0% invested in Aetna Inc. (NYSE:AET). Dekabank Deutsche Girozentrale invested in 0.1% or 81,065 shares. Tru Company Of Vermont accumulated 3,454 shares. Piedmont Investment Advsrs Ltd owns 13,936 shares. Umb Bancorp N A Mo holds 0.04% of its portfolio in Aetna Inc. (NYSE:AET) for 7,307 shares. First Republic Investment Mngmt reported 21,711 shares or 0.02% of all its holdings. State Treasurer State Of Michigan, Michigan-based fund reported 96,834 shares. First Quadrant Limited Partnership Ca owns 46,553 shares or 0.16% of their US portfolio. First Mercantile Tru Communications, Tennessee-based fund reported 1,787 shares. Lombard Odier Asset Mgmt (Europe) Limited holds 0.05% or 3,310 shares in its portfolio. Peak6 Invests Limited Partnership has 0.02% invested in Aetna Inc. (NYSE:AET) for 25,000 shares. Park Avenue Secs Ltd Company has invested 0.06% in Aetna Inc. (NYSE:AET). Twin Capital Management reported 0.73% of its portfolio in Aetna Inc. (NYSE:AET). Fayez Sarofim & reported 7,427 shares.

Gabelli Securities Inc increased its stake in Aetna Inc (B:Aet) Com (AET) by 22.68% based on its latest 2018Q2 regulatory filing with the SEC. Gabelli Securities Inc bought 34,200 shares as the company’s stock rose 8.54% with the market. The hedge fund held 185,000 shares of the medical specialities company at the end of 2018Q2, valued at $33.95M, up from 150,800 at the end of the previous reported quarter. Gabelli Securities Inc who had been investing in Aetna Inc (B:Aet) Com for a number of months, seems to be bullish on the $69.64B market cap company. The stock increased 0.33% or $0.7 during the last trading session, reaching $212.7. About 11.86 million shares traded or 333.85% up from the average. Aetna Inc. (NYSE:AET) has risen 24.93% since December 1, 2017 and is uptrending. It has outperformed by 9.31% the S&P500.

More notable recent Aetna Inc. (NYSE:AET) news were published by: Streetinsider.com which released: “DMHC Approves CVS’s (CVS) Acquisition of Aetna (AET) – StreetInsider.com” on November 15, 2018, also Bizjournals.com with their article: “CVS set to close $69B Aetna merger after final state approvals – Boston Business Journal” published on November 26, 2018, Seekingalpha.com published: “CVS-Aetna tie-up officially closes – Seeking Alpha” on November 28, 2018. More interesting news about Aetna Inc. (NYSE:AET) were released by: Seekingalpha.com and their article: “Hiccup in CVS-Aetna deal approval? – Seeking Alpha” published on November 30, 2018 as well as Fool.com‘s news article titled: “CVS Health’s Big Story in the 3rd Quarter: Ready for Aetna – Motley Fool” with publication date: November 06, 2018.

Aetna Inc. (NYSE:AET) Ratings Coverage

Among 4 analysts covering Aetna Inc (NYSE:AET), 0 have Buy rating, 0 Sell and 4 Hold. Therefore 0 are positive. Aetna Inc had 6 analyst reports since June 11, 2018 according to SRatingsIntel. PiperJaffray downgraded the shares of AET in report on Wednesday, October 31 to “Neutral” rating. The stock of Aetna Inc. (NYSE:AET) earned “Neutral” rating by Credit Suisse on Wednesday, October 31. The firm earned “Neutral” rating on Wednesday, October 31 by Citigroup. Cantor Fitzgerald downgraded the stock to “Neutral” rating in Thursday, August 23 report. Cantor Fitzgerald maintained Aetna Inc. (NYSE:AET) rating on Monday, June 11. Cantor Fitzgerald has “Buy” rating and $20200 target. Credit Suisse maintained Aetna Inc. (NYSE:AET) on Monday, October 22 with “Neutral” rating.

Aetna Inc. (NYSE:AET) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.